<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39319780</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">RP91849</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.91849</ELocationID><Abstract><AbstractText>Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but the contribution of this process to variability in annual epidemics is not well understood. Here, we link influenza A(H3N2) virus evolution to regional epidemic dynamics in the United States during 1997-2019. We integrate phenotypic measures of HA antigenic drift and sequence-based measures of HA and NA fitness to infer antigenic and genetic distances between viruses circulating in successive seasons. We estimate the magnitude, severity, timing, transmission rate, age-specific patterns, and subtype dominance of each regional outbreak and find that genetic distance based on broad sets of epitope sites is the strongest evolutionary predictor of A(H3N2) virus epidemiology. Increased HA and NA epitope distance between seasons correlates with larger, more intense epidemics, higher transmission, greater A(H3N2) subtype dominance, and a greater proportion of cases in adults relative to children, consistent with increased population susceptibility. Based on random forest models, A(H1N1) incidence impacts A(H3N2) epidemics to a greater extent than viral evolution, suggesting that subtype interference is a major driver of influenza A virus infection ynamics, presumably via heterosubtypic cross-immunity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perofsky</LastName><ForeName>Amanda C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0001-7341-9193</Identifier><AffiliationInfo><Affiliation>Fogarty International Center, National Institutes of Health, Bethesda, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huddleston</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4250-2063</Identifier><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Chelsea L</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0002-4526-6772</Identifier><AffiliationInfo><Affiliation>Fogarty International Center, National Institutes of Health, Bethesda, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowe</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondor</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2596-4282</Identifier><AffiliationInfo><Affiliation>Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wentworth</LastName><ForeName>David E</ForeName><Initials>DE</Initials><Identifier Source="ORCID">0000-0002-5190-980X</Identifier><AffiliationInfo><Affiliation>Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Lynne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ermetal</LastName><ForeName>Burcu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harvey</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galiano</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>Rodney Stuart</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0003-2818-5089</Identifier><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCauley</LastName><ForeName>John W</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0002-4744-6347</Identifier><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujisaki</LastName><ForeName>Seiichiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishida</LastName><ForeName>Noriko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Shinji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Sheena G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barr</LastName><ForeName>Ian G</ForeName><Initials>IG</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbarao</LastName><ForeName>Kanta</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1713-3056</Identifier><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krammer</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedford</LastName><ForeName>Trevor</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4039-5794</Identifier><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Seattle, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viboud</LastName><ForeName>Cécile</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3243-4711</Identifier><AffiliationInfo><Affiliation>Fogarty International Center, National Institutes of Health, Bethesda, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>10111800</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country /></Grant><Grant><GrantID>75N93019C00051</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>FC001030</GrantID><Acronym>ARC_</Acronym><Agency>Arthritis Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>10110400</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country /></Grant><Grant><GrantID>JP22fk0108118</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country /></Grant><Grant><GrantID>HHSN272201400008C</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AI140714</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93021C00014</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>75N93019C00051</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93021C00014</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI165821</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI165821</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN272201400008C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AI140714</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1354890</GrantID><Agency>National Science Foundation</Agency><Country /></Grant><Grant><GrantID>R35 GM119774</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>FC001030</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R35 GM119774</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI127893</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>FC001030</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>JP23fk0108662</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country /></Grant><Grant><GrantID>FC001030</GrantID><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 AI127893</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019267">Hemagglutinin Glycoproteins, Influenza Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.18</RegistryNumber><NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2024 May 22:2023.10.02.23296453. doi: 10.1101/2023.10.02.23296453</RefSource><PMID Version="1">37873362</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D053122" MajorTopicYN="Y">Influenza A Virus, H3N2 Subtype</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019267" MajorTopicYN="Y">Hemagglutinin Glycoproteins, Influenza Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088603" MajorTopicYN="Y">Antigenic Drift and Shift</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019143" MajorTopicYN="N">Evolution, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Seasonal influenza (flu) viruses cause outbreaks every winter. People infected with influenza typically develop mild respiratory symptoms. But flu infections can cause serious illness in young children, older adults and people with chronic medical conditions. Infected or vaccinated individuals develop some immunity, but the viruses evolve quickly to evade these defenses in a process called antigenic drift. As the viruses change, they can re-infect previously immune people. Scientists update the flu vaccine yearly to keep up with this antigenic drift. The immune system fights flu infections by recognizing two proteins, known as antigens, on the virus’s surface, called hemagglutinin (HA) and neuraminidase (NA). However, mutations in the genes encoding these proteins can make them unrecognizable, letting the virus slip past the immune system. Scientists would like to know how these changes affect the size, severity and timing of annual influenza outbreaks. Perofsky et al. show that tracking genetic changes in HA and NA may help improve flu season predictions. The experiments compared the severity of 22 flu seasons caused by the A(H3N2) subtype in the United States with how much HA and NA had evolved since the previous year. The A(H3N2) subtype experiences the fastest rates of antigenic drift and causes more cases and deaths than other seasonal flu viruses. Genetic changes in HA and NA were a better predictor of A(H3N2) outbreak severity than the blood tests for protective antibodies that epidemiologists traditionally use to track flu evolution. However, the prevalence of another subtype of influenza A circulating in the population, called A(H1N1), was an even better predictor of how severe A(H3N2) outbreaks would be. Perofsky et al. are the first to show that genetic changes in NA contribute to the severity of flu seasons. Previous studies suggested a link between genetic changes in HA and flu season severity, and flu vaccines include the HA protein to help the body recognize new influenza strains. The results suggest that adding the NA protein to flu vaccines may improve their effectiveness. In the future, flu forecasters may want to analyze genetic changes in both NA and HA to make their outbreak predictions. Tracking how much of the A(H1N1) subtype is circulating may also be useful for predicting the severity of A(H3N2) outbreaks.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">H3N2</Keyword><Keyword MajorTopicYN="N">antigenic drift</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">global health</Keyword><Keyword MajorTopicYN="N">human</Keyword><Keyword MajorTopicYN="N">infectious disease</Keyword><Keyword MajorTopicYN="N">influenza virus</Keyword><Keyword MajorTopicYN="N">microbiology</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>AP, JH, JB, TR, XX, RK, DW, NL, LW, BE, RH, MG, RD, SF, KN, NK, SW, HH, TB No competing interests declared, CH Received personal fees from Sanofi outside the submitted work, JM Received consulting fees, honoraria, and travel support from Sanofi Pasteur and Sequris, SS The WHO Collaborating Centre for Reference and Research on Influenza in Melbourne has a collaborative research and development agreement (CRADA) with CSL Seqirus for isolation of candidate vaccine viruses in cells and an agreement with IFPMA for isolation of candidate vaccine viruses in eggs. SGS reports honoraria from CSL Seqirus, Moderna, Pfizer, and Evo Health, IB, KS The WHO Collaborating Centre for Reference and Research on Influenza in Melbourne has a collaborative research and development agreement (CRADA) with CSL Seqirus for isolation of candidate vaccine viruses in cells and an agreement with IFPMA for isolation of candidate vaccine viruses in eggs, FK The Icahn School of Medicine at Mount Sinai has filed patent applications relating to influenza virus vaccines (U.S. patent numbers: 12030928, 11865173, 11266734, 11254733, 10736956, 10583188, 10137189, 10131695, 9968670, 9371366; publication numbers: 20230181715, 20220403358, 20220249652, 20220242935, 20220153873, 20210260179, 20190125859, 20190106461, 20180333479), SARS-CoV-2 serological assays (publication number: 20240210415), and SARS-CoV-2 vaccines (publication numbers: 20230310583, 20230226171), which list FK as co-inventor. FK has consulted for Merck and Pfizer (before 2020), and is currently consulting for Pfizer, Seqirus, 3rd Rock Ventures, GSK and Avimex. The Krammer laboratory is also collaborating with Pfizer on animal models of SARS‐CoV‐2 and with Dynavax on universal influenza virus vaccines, CV Received honoraria for serving as an Editor in Chief of the journal Epidemics (Elsevier)</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39319780</ArticleId><ArticleId IdType="pmc">PMC11424097</ArticleId><ArticleId IdType="doi">10.7554/eLife.91849</ArticleId><ArticleId IdType="pii">91849</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ali ST, Lau YC, Shan S, Ryu S, Du Z, Wang L, Xu XK, Chen D, Xiong J, Tae J, Tsang TK, Wu P, Lau EHY, Cowling BJ. Prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic: a modelling study. The Lancet. Global Health. 2022;10:e1612–e1622. doi: 10.1016/S2214-109X(22)00358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00358-8</ArticleId><ArticleId IdType="pmc">PMC9573849</ArticleId><ArticleId IdType="pubmed">36240828</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman MO, Bennink JR, Yewdell JW, Herrin BR. Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity. eLife. 2015;4:e07467. doi: 10.7554/eLife.07467.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.07467</ArticleId><ArticleId IdType="pmc">PMC4552221</ArticleId><ArticleId IdType="pubmed">26252514</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann A, Toloşi L, Sander O, Lengauer T. Permutation importance: a corrected feature importance measure. Bioinformatics. 2010;26:1340–1347. doi: 10.1093/bioinformatics/btq134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq134</ArticleId><ArticleId IdType="pubmed">20385727</ArticleId></ArticleIdList></Reference><Reference><Citation>Axelsen JB, Yaari R, Grenfell BT, Stone L. Multiannual forecasting of seasonal influenza dynamics reveals climatic and evolutionary drivers. PNAS. 2014;111:9538–9542. doi: 10.1073/pnas.1321656111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1321656111</ArticleId><ArticleId IdType="pmc">PMC4084473</ArticleId><ArticleId IdType="pubmed">24979763</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. PNAS. 2020;117:30547–30553. doi: 10.1073/pnas.2013182117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2013182117</ArticleId><ArticleId IdType="pmc">PMC7720203</ArticleId><ArticleId IdType="pubmed">33168723</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford T, Cobey S, Beerli P, Pascual M. Global migration dynamics underlie evolution and persistence of human influenza A (H3N2) PLOS Pathogens. 2010;6:e1000918. doi: 10.1371/journal.ppat.1000918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000918</ArticleId><ArticleId IdType="pmc">PMC2877742</ArticleId><ArticleId IdType="pubmed">20523898</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford T, Cobey S, Pascual M. Strength and tempo of selection revealed in viral gene genealogies. BMC Evolutionary Biology. 2011;11:220. doi: 10.1186/1471-2148-11-220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2148-11-220</ArticleId><ArticleId IdType="pmc">PMC3199772</ArticleId><ArticleId IdType="pubmed">21787390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford T, Rambaut A, Pascual M. Canalization of the evolutionary trajectory of the human influenza virus. BMC Biology. 2012;10:38. doi: 10.1186/1741-7007-10-38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7007-10-38</ArticleId><ArticleId IdType="pmc">PMC3373370</ArticleId><ArticleId IdType="pubmed">22546494</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, McCauley JW, Russell CA, Smith DJ, Rambaut A. Integrating influenza antigenic dynamics with molecular evolution. eLife. 2014;3:e01914. doi: 10.7554/eLife.01914.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.01914</ArticleId><ArticleId IdType="pmc">PMC3909918</ArticleId><ArticleId IdType="pubmed">24497547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, Klimov A, Lewis NS, Li X, McCauley JW, Odagiri T, Potdar V, Rambaut A, Shu Y, Skepner E, Smith DJ, Suchard MA, Tashiro M, Wang D, Xu X, Lemey P, Russell CA. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. Nature. 2015;523:217–220. doi: 10.1038/nature14460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14460</ArticleId><ArticleId IdType="pmc">PMC4499780</ArticleId><ArticleId IdType="pubmed">26053121</ArticleId></ArticleIdList></Reference><Reference><Citation>Belongia EA, Kieke BA, Donahue JG, Coleman LA, Irving SA, Meece JK, Vandermause M, Lindstrom S, Gargiullo P, Shay DK. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine. 2011;29:6558–6563. doi: 10.1016/j.vaccine.2011.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.07.002</ArticleId><ArticleId IdType="pubmed">21767593</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B. 1995;57:289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S, Holmes EC, Pybus OG. The genomic rate of molecular adaptation of the human influenza A virus. Molecular Biology and Evolution. 2011;28:2443–2451. doi: 10.1093/molbev/msr044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msr044</ArticleId><ArticleId IdType="pmc">PMC3163432</ArticleId><ArticleId IdType="pubmed">21415025</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S, Ferguson N, Flaxman S, Gandy A, Mishra S, Scott JA. Semi-mechanistic Bayesian modelling of COVID-19 with renewal processes. Journal of the Royal Statistical Society Series A. 2023;186:601–615. doi: 10.1093/jrsssa/qnad030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jrsssa/qnad030</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infectious Diseases. 2014a;14:480. doi: 10.1186/1471-2334-14-480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-480</ArticleId><ArticleId IdType="pmc">PMC4169819</ArticleId><ArticleId IdType="pubmed">25186370</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggerstaff M, Jhung MA, Reed C, Fry AM, Balluz L, Finelli L. Influenza-like illness, the time to seek healthcare, and influenza antiviral receipt during the 2010-2011 influenza season-United States. The Journal of Infectious Diseases. 2014b;210:535–544. doi: 10.1093/infdis/jiu224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu224</ArticleId><ArticleId IdType="pmc">PMC4610008</ArticleId><ArticleId IdType="pubmed">24731959</ArticleId></ArticleIdList></Reference><Reference><Citation>Boni MF, Gog JR, Andreasen V, Christiansen FB. Influenza drift and epidemic size: the race between generating and escaping immunity. Theoretical Population Biology. 2004;65:179–191. doi: 10.1016/j.tpb.2003.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tpb.2003.10.002</ArticleId><ArticleId IdType="pubmed">14766191</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett IC, Johansson BE. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in A murine model system. Virology. 2005;339:273–280. doi: 10.1016/j.virol.2005.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.06.006</ArticleId><ArticleId IdType="pubmed">15996702</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA. 2000;284:1655–1663. doi: 10.1001/jama.284.13.1655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.284.13.1655</ArticleId><ArticleId IdType="pubmed">11015795</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. Predicting the evolution of human influenza A. Science. 1999;286:1921–1925. doi: 10.1126/science.286.5446.1921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.286.5446.1921</ArticleId><ArticleId IdType="pubmed">10583948</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter B, Gelman A, Hoffman MD, Lee D, Goodrich B, Betancourt M, Brubaker MA, Guo J, Li P, Riddell A. Stan: a probabilistic programming language. Journal of Statistical Software. 2017;76:1–32. doi: 10.18637/jss.v076.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v076.i01</ArticleId><ArticleId IdType="pmc">PMC9788645</ArticleId><ArticleId IdType="pubmed">36568334</ArticleId></ArticleIdList></Reference><Reference><Citation>Castilla J, Navascués A, Fernández-Alonso M, Reina G, Pozo F, Casado I, Guevara M, Martínez-Baz I, Barricarte A, Ezpeleta C, Primary Health Care Sentinel Network. Network for Influenza Surveillance in Hospitals of Navarra Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. Vaccine. 2016;34:1350–1357. doi: 10.1016/j.vaccine.2016.01.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.01.054</ArticleId><ArticleId IdType="pubmed">26854911</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults—Colorado, 2003. MMWR. Morbidity and Mortality Weekly Report. 2004;53:707–710.</Citation><ArticleIdList><ArticleId IdType="pubmed">15306754</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases  Flu Vaccination Coverage, United States, 2018–19 Influenza Season. 2019.  [March 20, 2023]. https://www.cdc.gov/flu/fluvaxview/coverage-1819estimates.htm</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases  FluView Interactive. 2023a.  [October 20, 2023]. https://www.cdc.gov/flu/weekly/fluviewinteractive.htm</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases  U.S. influenza surveillance: purpose and methods. 2023b.  [April 24, 2022]. https://www.cdc.gov/flu/weekly/overview.htm</Citation></Reference><Reference><Citation>Chao A, Gotelli NJ, Hsieh TC, Sander EL, Ma KH, Colwell RK, Ellison AM. Rarefaction and extrapolation with Hill numbers: a framework for sampling and estimation in species diversity studies. Ecological Monographs. 2014;84:45–67. doi: 10.1890/13-0133.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1890/13-0133.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Charu V, Zeger S, Gog J, Bjørnstad ON, Kissler S, Simonsen L, Grenfell BT, Viboud C. Human mobility and the spatial transmission of influenza in the United States. PLOS Computational Biology. 2017;13:e1005382. doi: 10.1371/journal.pcbi.1005382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005382</ArticleId><ArticleId IdType="pmc">PMC5349690</ArticleId><ArticleId IdType="pubmed">28187123</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay I, Kiciman E, Elliott JW, Shaman JL, Rzhetsky A. Conjunction of factors triggering waves of seasonal influenza. eLife. 2018;7:e30756. doi: 10.7554/eLife.30756.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30756</ArticleId><ArticleId IdType="pmc">PMC5864297</ArticleId><ArticleId IdType="pubmed">29485041</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YQ, Wohlbold TJ, Zheng NY, Huang M, Huang Y, Neu KE, Lee J, Wan H, Rojas KT, Kirkpatrick E, Henry C, Palm AKE, Stamper CT, Lan LYL, Topham DJ, Treanor J, Wrammert J, Ahmed R, Eichelberger MC, Georgiou G, Krammer F, Wilson PC. Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell. 2018;173:417–429. doi: 10.1016/j.cell.2018.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.030</ArticleId><ArticleId IdType="pmc">PMC5890936</ArticleId><ArticleId IdType="pubmed">29625056</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobey S, Hensley SE. Immune history and influenza virus susceptibility. Current Opinion in Virology. 2017;22:105–111. doi: 10.1016/j.coviro.2016.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2016.12.004</ArticleId><ArticleId IdType="pmc">PMC5467731</ArticleId><ArticleId IdType="pubmed">28088686</ArticleId></ArticleIdList></Reference><Reference><Citation>Cori A, Ferguson NM, Fraser C, Cauchemez S. A new framework and software to estimate time-varying reproduction numbers during epidemics. American Journal of Epidemiology. 2013;178:1505–1512. doi: 10.1093/aje/kwt133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt133</ArticleId><ArticleId IdType="pmc">PMC3816335</ArticleId><ArticleId IdType="pubmed">24043437</ArticleId></ArticleIdList></Reference><Reference><Citation>Couch RB, Kasel JA, Gerin JL, Schulman JL, Kilbourne ED. Induction of partial immunity to influenza by a neuraminidase-specific vaccine. The Journal of Infectious Diseases. 1974;129:411–420. doi: 10.1093/infdis/129.4.411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.4.411</ArticleId><ArticleId IdType="pubmed">4593871</ArticleId></ArticleIdList></Reference><Reference><Citation>Couch RB, Atmar RL, Franco LM, Quarles JM, Wells J, Arden N, Niño D, Belmont JW. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. The Journal of Infectious Diseases. 2013;207:974–981. doi: 10.1093/infdis/jis935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis935</ArticleId><ArticleId IdType="pmc">PMC3633450</ArticleId><ArticleId IdType="pubmed">23307936</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowling BJ, Fang VJ, Riley S, Malik Peiris JS, Leung GM. Estimation of the serial interval of influenza. Epidemiology. 2009;20:344–347. doi: 10.1097/EDE.0b013e31819d1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e31819d1092</ArticleId><ArticleId IdType="pmc">PMC3057478</ArticleId><ArticleId IdType="pubmed">19279492</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowling BJ, Ng S, Ma ESK, Cheng CKY, Wai W, Fang VJ, Chan K-H, Ip DKM, Chiu SS, Peiris JSM, Leung GM. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clinical Infectious Diseases. 2010;51:1370–1379. doi: 10.1086/657311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/657311</ArticleId><ArticleId IdType="pubmed">21067351</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowling BJ, Perera RAPM, Fang VJ, Chan K-H, Wai W, So HC, Chu DKW, Wong JY, Shiu EY, Ng S, Ip DKM, Peiris JSM, Leung GM. Incidence of influenza virus infections in children in Hong Kong in a 3-year randomized placebo-controlled vaccine study, 2009-2012. Clinical Infectious Diseases. 2014;59:517–524. doi: 10.1093/cid/ciu356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu356</ArticleId><ArticleId IdType="pubmed">24825868</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, Fong MW, Liao Q, Kwan MY, Lee SL, Chiu SS, Wu JT, Wu P, Leung GM. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. The Lancet. Public Health. 2020;5:e279–e288. doi: 10.1016/S2468-2667(20)30090-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30090-6</ArticleId><ArticleId IdType="pmc">PMC7164922</ArticleId><ArticleId IdType="pubmed">32311320</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalziel BD, Kissler S, Gog JR, Viboud C, Bjørnstad ON, Metcalf CJE, Grenfell BT. Urbanization and humidity shape the intensity of influenza epidemics in U.S. cities. Science. 2018;362:75–79. doi: 10.1126/science.aat6030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat6030</ArticleId><ArticleId IdType="pmc">PMC6510303</ArticleId><ArticleId IdType="pubmed">30287659</ArticleId></ArticleIdList></Reference><Reference><Citation>Debeer D, Strobl C. Conditional permutation importance revisited. BMC Bioinformatics. 2020;21:307. doi: 10.1186/s12859-020-03622-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-020-03622-2</ArticleId><ArticleId IdType="pmc">PMC7362659</ArticleId><ArticleId IdType="pubmed">32664864</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanasekaran V, Sullivan S, Edwards KM, Xie R, Khvorov A, Valkenburg SA, Cowling BJ, Barr IG. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nature Communications. 2022;13:1721. doi: 10.1038/s41467-022-29402-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29402-5</ArticleId><ArticleId IdType="pmc">PMC8971476</ArticleId><ArticleId IdType="pubmed">35361789</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X, King AA, Woods RJ, Pascual M. Evolution-informed forecasting of seasonal influenza A (H3N2) Science Translational Medicine. 2017;9:eaan5325. doi: 10.1126/scitranslmed.aan5325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aan5325</ArticleId><ArticleId IdType="pmc">PMC5805486</ArticleId><ArticleId IdType="pubmed">29070700</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichelberger MC, Morens DM, Taubenberger JK. Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness. Current Opinion in Immunology. 2018;53:38–44. doi: 10.1016/j.coi.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6141346</ArticleId><ArticleId IdType="pubmed">29674167</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein SL. Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957: an experiment of nature. The Journal of Infectious Diseases. 2006;193:49–53. doi: 10.1086/498980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/498980</ArticleId><ArticleId IdType="pubmed">16323131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature. 2003;422:428–433. doi: 10.1038/nature01509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01509</ArticleId><ArticleId IdType="pubmed">12660783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, Meeyai A, Iamsirithaworn S, Burke DS. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005;437:209–214. doi: 10.1038/nature04017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04017</ArticleId><ArticleId IdType="pubmed">16079797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari S, Cribari-Neto F. Beta regression for modelling rates and proportions. Journal of Applied Statistics. 2004;31:799–815. doi: 10.1080/0266476042000214501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0266476042000214501</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ, Centers for Disease Control and Prevention Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR. Recommendations and Reports. 2009;58:1–52.</Citation><ArticleIdList><ArticleId IdType="pubmed">19644442</ArticleId></ArticleIdList></Reference><Reference><Citation>Flannery B, Zimmerman RK, Gubareva LV, Garten RJ, Chung JR, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Ohmit SE, Belongia EA, McLean HQ, Gaglani M, Piedra PA, Mishin VP, Chesnokov AP, Spencer S, Thaker SN, Barnes JR, Foust A, Sessions W, Xu X, Katz J, Fry AM. Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015. The Journal of Infectious Diseases. 2016;214:1010–1019. doi: 10.1093/infdis/jiw181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw181</ArticleId><ArticleId IdType="pmc">PMC5812259</ArticleId><ArticleId IdType="pubmed">27190176</ArticleId></ArticleIdList></Reference><Reference><Citation>Flannery B, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Rolfes MA, Spencer S, Fry AM, Investigators USFV. Influenza vaccine effectiveness in the united states during the 2016-2017 season. Clinical Infectious Diseases. 2019;68:1798–1806. doi: 10.1093/cid/ciy775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy775</ArticleId><ArticleId IdType="pmc">PMC6522684</ArticleId><ArticleId IdType="pubmed">30204854</ArticleId></ArticleIdList></Reference><Reference><Citation>Flannery B, Kondor RJG, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Kim SS, Blanton L, Kniss K, Budd AP, Brammer L, Stark TJ, Barnes JR, Wentworth DE, Fry AM, Patel M. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the united states during the 2018-2019 Season. The Journal of Infectious Diseases. 2020;221:8–15. doi: 10.1093/infdis/jiz543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz543</ArticleId><ArticleId IdType="pmc">PMC7325528</ArticleId><ArticleId IdType="pubmed">31665373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox SJ, Miller JC, Meyers LA. Seasonality in risk of pandemic influenza emergence. PLOS Computational Biology. 2017;13:e1005749. doi: 10.1371/journal.pcbi.1005749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005749</ArticleId><ArticleId IdType="pmc">PMC5654262</ArticleId><ArticleId IdType="pubmed">29049288</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. Journal of Statistical Software. 2010;33:1–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP, Zimmerman RK, Jackson ML, Jackson LA, Petrie JG, Ohmit SE, Monto AS, McLean HQ, Belongia EA, Fry AM, Flannery B. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013-2014 in the United States. The Journal of Infectious Diseases. 2016;213:1546–1556. doi: 10.1093/infdis/jiv577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv577</ArticleId><ArticleId IdType="pmc">PMC4837903</ArticleId><ArticleId IdType="pubmed">26743842</ArticleId></ArticleIdList></Reference><Reference><Citation>Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RAM, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD, Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325:197–201. doi: 10.1126/science.1176225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1176225</ArticleId><ArticleId IdType="pmc">PMC3250984</ArticleId><ArticleId IdType="pubmed">19465683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti L, Koenen MH, Zhang JD, Anisimova M, Verhagen LM, Schutten M, Osterhaus A, van der Vries E. Cross-reactive immunity potentially drives global oscillation and opposed alternation patterns of seasonal influenza A viruses. Scientific Reports. 2022;12:8883. doi: 10.1038/s41598-022-08233-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08233-w</ArticleId><ArticleId IdType="pmc">PMC9131982</ArticleId><ArticleId IdType="pubmed">35614123</ArticleId></ArticleIdList></Reference><Reference><Citation>Geoghegan JL, Saavedra AF, Duchêne S, Sullivan S, Barr I, Holmes EC. Continental synchronicity of human influenza virus epidemics despite climatic variation. PLOS Pathogens. 2018;14:e1006780. doi: 10.1371/journal.ppat.1006780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006780</ArticleId><ArticleId IdType="pmc">PMC5764404</ArticleId><ArticleId IdType="pubmed">29324895</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdil C. The annual production cycle for influenza vaccine. Vaccine. 2003;21:1776–1779. doi: 10.1016/s0264-410x(03)00071-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0264-410x(03)00071-9</ArticleId><ArticleId IdType="pubmed">12686093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill PW, Murphy AM. Naturally acquired immunity to influenza type A: A further prospective study. The Medical Journal of Australia. 1977;2:761–765. doi: 10.5694/j.1326-5377.1977.tb99276.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.1977.tb99276.x</ArticleId><ArticleId IdType="pubmed">611373</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein E, Cobey S, Takahashi S, Miller JC, Lipsitch M. Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: A statistical method. PLOS Medicine. 2011;8:e1001051. doi: 10.1371/journal.pmed.1001051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001051</ArticleId><ArticleId IdType="pmc">PMC3130020</ArticleId><ArticleId IdType="pubmed">21750666</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong LI, Suchard MA, Bloom JD. Stability-mediated epistasis constrains the evolution of an influenza protein. eLife. 2013;2:e00631. doi: 10.7554/eLife.00631.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.00631</ArticleId><ArticleId IdType="pmc">PMC3654441</ArticleId><ArticleId IdType="pubmed">23682315</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostic KM, Bridge R, Brady S, Viboud C, Worobey M, Lloyd-Smith JO. Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics. PLOS Pathogens. 2019;15:e1008109. doi: 10.1371/journal.ppat.1008109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008109</ArticleId><ArticleId IdType="pmc">PMC6922319</ArticleId><ArticleId IdType="pubmed">31856206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostic KM, McGough L, Baskerville EB, Abbott S, Joshi K, Tedijanto C, Kahn R, Niehus R, Hay JA, De Salazar PM, Hellewell J, Meakin S, Munday JD, Bosse NI, Sherrat K, Thompson RN, White LF, Huisman JS, Scire J, Bonhoeffer S, Stadler T, Wallinga J, Funk S, Lipsitch M, Cobey S. Practical considerations for measuring the effective reproductive number, Rt. PLOS Computational Biology. 2020;16:e1008409. doi: 10.1371/journal.pcbi.1008409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008409</ArticleId><ArticleId IdType="pmc">PMC7728287</ArticleId><ArticleId IdType="pubmed">33301457</ArticleId></ArticleIdList></Reference><Reference><Citation>Grebe KM, Yewdell JW, Bennink JR. Heterosubtypic immunity to influenza A virus: where do we stand? Microbes and Infection. 2008;10:1024–1029. doi: 10.1016/j.micinf.2008.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2008.07.002</ArticleId><ArticleId IdType="pmc">PMC2584237</ArticleId><ArticleId IdType="pubmed">18662798</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene SK, Ionides EL, Wilson ML. Patterns of influenza-associated mortality among US elderly by geographic region and virus subtype, 1968-1998. American Journal of Epidemiology. 2006;163:316–326. doi: 10.1093/aje/kwj040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwj040</ArticleId><ArticleId IdType="pubmed">16394205</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenfell BT, Bjørnstad ON, Kappey J. Travelling waves and spatial hierarchies in measles epidemics. Nature. 2001;414:716–723. doi: 10.1038/414716a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/414716a</ArticleId><ArticleId IdType="pubmed">11742391</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, Sagulenko P, Bedford T, Neher RA. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121–4123. doi: 10.1093/bioinformatics/bty407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty407</ArticleId><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen CL, Chaves SS, Demont C, Viboud C. Mortality associated with influenza and respiratory syncytial virus in the US, 1999-2018. JAMA Network Open. 2022;5:e220527. doi: 10.1001/jamanetworkopen.2022.0527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.0527</ArticleId><ArticleId IdType="pmc">PMC8886548</ArticleId><ArticleId IdType="pubmed">35226079</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2001;356:1861–1870. doi: 10.1098/rstb.2001.0999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2001.0999</ArticleId><ArticleId IdType="pmc">PMC1088562</ArticleId><ArticleId IdType="pubmed">11779385</ArticleId></ArticleIdList></Reference><Reference><Citation>He D, Lui R, Wang L, Tse CK, Yang L, Stone L. Global spatio-temporal patterns of influenza in the post-pandemic Era. Scientific Reports. 2015;5:11013. doi: 10.1038/srep11013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11013</ArticleId><ArticleId IdType="pmc">PMC4457022</ArticleId><ArticleId IdType="pubmed">26046930</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry C, Zheng N-Y, Huang M, Cabanov A, Rojas KT, Kaur K, Andrews SF, Palm A-KE, Chen Y-Q, Li Y, Hoskova K, Utset HA, Vieira MC, Wrammert J, Ahmed R, Holden-Wiltse J, Topham DJ, Treanor JJ, Ertl HC, Schmader KE, Cobey S, Krammer F, Hensley SE, Greenberg H, He X-S, Wilson PC. Influenza virus vaccination elicits poorly adapted b cell responses in elderly individuals. Cell Host &amp; Microbe. 2019;25:357–366. doi: 10.1016/j.chom.2019.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.01.002</ArticleId><ArticleId IdType="pmc">PMC6452894</ArticleId><ArticleId IdType="pubmed">30795982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensley SE. Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Current Opinion in Virology. 2014;8:85–89. doi: 10.1016/j.coviro.2014.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.07.007</ArticleId><ArticleId IdType="pmc">PMC4195845</ArticleId><ArticleId IdType="pubmed">25108824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill MO. Diversity and evenness: a unifying notation and its consequences. Ecology. 1973;54:427–432. doi: 10.2307/1934352.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/1934352</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman MD, Gelman A. The No-U-Turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo. Journal of Machine Learning Research: JMLR. 2014;15:1593–1623.</Citation></Reference><Reference><Citation>Hope-Simpson RE. Hong Kong influenza variant. British Medical Journal. 1971;3:531. doi: 10.1136/bmj.3.5773.531-b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.3.5773.531-b</ArticleId><ArticleId IdType="pmc">PMC1800547</ArticleId><ArticleId IdType="pubmed">5570648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hothorn T, Bühlmann P, Dudoit S, Molinaro A, van der Laan MJ. Survival ensembles. Biostatistics. 2006;7:355–373. doi: 10.1093/biostatistics/kxj011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxj011</ArticleId><ArticleId IdType="pubmed">16344280</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, Nesdale A, Dowell T, Turner N, Campbell-Stokes P, Balm M, Dobinson HC, Grant CC, James S, Aminisani N, Ralston J, Gunn W, Bocacao J, Danielewicz J, Moncrieff T, McNeill A, Lopez L, Waite B, Kiedrzynski T, Schrader H, Gray R, Cook K, Currin D, Engelbrecht C, Tapurau W, Emmerton L, Martin M, Baker MG, Taylor S, Trenholme A, Wong C, Lawrence S, McArthur C, Stanley A, Roberts S, Rahnama F, Bennett J, Mansell C, Dilcher M, Werno A, Grant J, van der Linden A, Youngblood B, Thomas PG, NPIsImpactOnFlu Consortium. Webby RJ. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nature Communications. 2021;12:1001. doi: 10.1038/s41467-021-21157-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21157-9</ArticleId><ArticleId IdType="pmc">PMC7881137</ArticleId><ArticleId IdType="pubmed">33579926</ArticleId></ArticleIdList></Reference><Reference><Citation>Huddleston J, Barnes JR, Rowe T, Xu X, Kondor R, Wentworth DE, Whittaker L, Ermetal B, Daniels RS, McCauley JW, Fujisaki S, Nakamura K, Kishida N, Watanabe S, Hasegawa H, Barr I, Subbarao K, Barrat-Charlaix P, Neher RA, Bedford T. Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution. eLife. 2020;9:e60067. doi: 10.7554/eLife.60067.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60067</ArticleId><ArticleId IdType="pmc">PMC7553778</ArticleId><ArticleId IdType="pubmed">32876050</ArticleId></ArticleIdList></Reference><Reference><Citation>Huddleston J, Hadfield J, Sibley TR, Lee J, Fay K, Ilcisin M, Harkins E, Bedford T, Neher RA, Hodcroft EB. Augur: a bioinformatics toolkit for phylogenetic analyses of human pathogens. Journal of Open Source Software. 2021;6:2906. doi: 10.21105/joss.02906.</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.02906</ArticleId><ArticleId IdType="pmc">PMC8237802</ArticleId><ArticleId IdType="pubmed">34189396</ArticleId></ArticleIdList></Reference><Reference><Citation>Huddleston J. Perofsky-ili-antigenicity. swh:1:rev:b6591ed767bff9c7f9caec216ebe72e031d20042Software Heritage. 2024 https://archive.softwareheritage.org/swh:1:dir:dacc6ef9ae3eb7dd200f5c0cc82be349488e099a;origin=https://github.com/blab/perofsky-ili-antigenicity;visit=swh:1:snp:ecc390c30ff7f27e799b29262e126dcff41d2d7e;anchor=swh:1:rev:b6591ed767bff9c7f9caec216ebe72e031d20042</Citation></Reference><Reference><Citation>Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B. Influenza vaccine effectiveness in the United States during the 2015-2016 Season. The New England Journal of Medicine. 2017;377:534–543. doi: 10.1056/NEJMoa1700153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1700153</ArticleId><ArticleId IdType="pmc">PMC5727917</ArticleId><ArticleId IdType="pubmed">28792867</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang SH, Kang J. Factors associated with influenza vaccination uptake among U.S. adults: focus on nativity and race/ethnicity. International Journal of Environmental Research and Public Health. 2021;18:5349. doi: 10.3390/ijerph18105349.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18105349</ArticleId><ArticleId IdType="pmc">PMC8157050</ArticleId><ArticleId IdType="pubmed">34067932</ArticleId></ArticleIdList></Reference><Reference><Citation>Janjua NZ, Skowronski DM, De Serres G, Dickinson J, Crowcroft NS, Taylor M, Winter A-L, Hottes TS, Fonseca K, Charest H, Drews SJ, Sabaiduc S, Bastien N, Li Y, Gardy JL, Petric M. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada’s sentinel surveillance system: cross-protection against major and minor variants. The Journal of Infectious Diseases. 2012;205:1858–1868. doi: 10.1093/infdis/jis283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis283</ArticleId><ArticleId IdType="pubmed">22492921</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson BE, Grajower B, Kilbourne ED. Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice. Vaccine. 1993;11:1037–1039. doi: 10.1016/0264-410x(93)90130-p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0264-410x(93)90130-p</ArticleId><ArticleId IdType="pubmed">8212824</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson MA, Cummings DAT, Glass GE. Multiyear climate variability and dengue--El Niño southern oscillation, weather, and dengue incidence in Puerto Rico, Mexico, and Thailand: a longitudinal data analysis. PLOS Medicine. 2009;6:e1000168. doi: 10.1371/journal.pmed.1000168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000168</ArticleId><ArticleId IdType="pmc">PMC2771282</ArticleId><ArticleId IdType="pubmed">19918363</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Research. 2002;30:3059–3066. doi: 10.1093/nar/gkf436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkf436</ArticleId><ArticleId IdType="pmc">PMC135756</ArticleId><ArticleId IdType="pubmed">12136088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, Tsuchimoto T, Kashiwagi S. A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine. 2003;21:4507–4513. doi: 10.1016/s0264-410x(03)00508-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0264-410x(03)00508-5</ArticleId><ArticleId IdType="pubmed">14575760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilbourne ED. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans. The Journal of Infectious Diseases. 1976;134:384–394. doi: 10.1093/infdis/134.4.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/134.4.384</ArticleId><ArticleId IdType="pubmed">789791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilbourne ED, Johansson BE, Grajower B. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. PNAS. 1990;87:786–790. doi: 10.1073/pnas.87.2.786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.2.786</ArticleId><ArticleId IdType="pmc">PMC53351</ArticleId><ArticleId IdType="pubmed">2300562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick E, Qiu X, Wilson PC, Bahl J, Krammer F. The influenza virus hemagglutinin head evolves faster than the stalk domain. Scientific Reports. 2018;8:10432. doi: 10.1038/s41598-018-28706-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28706-1</ArticleId><ArticleId IdType="pmc">PMC6041311</ArticleId><ArticleId IdType="pubmed">29992986</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, Pitigoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, Jiménez-Jorge S, Horváth JK, Daviaud I, Guiomar R, Necula G, Bella A, O’Donnell J, Głuchowska M, Ciancio BC, Nicoll A, Moren A. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveillance. 2013;18:20390. doi: 10.2807/ese.18.05.20390-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.18.05.20390-en</ArticleId><ArticleId IdType="pubmed">23399425</ArticleId></ArticleIdList></Reference><Reference><Citation>Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GCM, Vervaet G, Skepner E, Lewis NS, Spronken MIJ, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus A, Fouchier RAM, Smith DJ. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science. 2013;342:976–979. doi: 10.1126/science.1244730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1244730</ArticleId><ArticleId IdType="pubmed">24264991</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelle K, Cobey S, Grenfell B, Pascual M. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science. 2006;314:1898–1903. doi: 10.1126/science.1132745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1132745</ArticleId><ArticleId IdType="pubmed">17185596</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelle K, Kamradt M, Pascual M. Understanding the dynamics of rapidly evolving pathogens through modeling the tempo of antigenic change: influenza as a case study. Epidemics. 2009;1:129–137. doi: 10.1016/j.epidem.2009.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2009.05.003</ArticleId><ArticleId IdType="pubmed">21352760</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelle K, Rasmussen DA. The effects of A deleterious mutation load on patterns of influenza A/H3N2’s antigenic evolution in humans. eLife. 2015;4:e07361. doi: 10.7554/eLife.07361.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.07361</ArticleId><ArticleId IdType="pmc">PMC4611170</ArticleId><ArticleId IdType="pubmed">26371556</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer SC, Shaman J. Development and validation of influenza forecasting for 64 temperate and tropical countries. PLOS Computational Biology. 2019;15:e1006742. doi: 10.1371/journal.pcbi.1006742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1006742</ArticleId><ArticleId IdType="pmc">PMC6411231</ArticleId><ArticleId IdType="pubmed">30811396</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F, Fouchier RAM, Eichelberger MC, Webby RJ, Shaw-Saliba K, Wan H, Wilson PC, Compans RW, Skountzou I, Monto AS. NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines? mBio. 2018;9:e02332-17. doi: 10.1128/mBio.02332-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02332-17</ArticleId><ArticleId IdType="pmc">PMC5885027</ArticleId><ArticleId IdType="pubmed">29615508</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F. The human antibody response to influenza A virus infection and vaccination. Nature Reviews. Immunology. 2019;19:383–397. doi: 10.1038/s41577-019-0143-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0143-6</ArticleId><ArticleId IdType="pubmed">30837674</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F. Unpublished influenza N2 epitope sites. afa8e58Github. 2023 https://github.com/blab/perofsky-ili-antigenicity/blob/master/config/distance_maps/h3n2/na/krammer.json</Citation></Reference><Reference><Citation>Kryazhimskiy S, Dushoff J, Bazykin GA, Plotkin JB. Prevalence of epistasis in the evolution of influenza A surface proteins. PLOS Genetics. 2011;7:e1001301. doi: 10.1371/journal.pgen.1001301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1001301</ArticleId><ArticleId IdType="pmc">PMC3040651</ArticleId><ArticleId IdType="pubmed">21390205</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M. Building predictive models in R using the caret package. Journal of Statistical Software. 2008;28:1–26. doi: 10.18637/jss.v028.i05.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v028.i05</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M, Johnson K. Applied Predictive Modeling. Springer; 2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-6849-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M, Johnson K. Feature engineering and selection: a practical approach for predictive models. Chapman and Hall/CRC; 2019.</Citation></Reference><Reference><Citation>Lam EKS, Morris DH, Hurt AC, Barr IG, Russell CA. The impact of climate and antigenic evolution on seasonal influenza virus epidemics in Australia. Nature Communications. 2020;11:2741. doi: 10.1038/s41467-020-16545-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16545-6</ArticleId><ArticleId IdType="pmc">PMC7265451</ArticleId><ArticleId IdType="pubmed">32488106</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurie KL, Guarnaccia TA, Carolan LA, Yan AWC, Aban M, Petrie S, Cao P, Heffernan JM, McVernon J, Mosse J, Kelso A, McCaw JM, Barr IG. Interval between infections and viral hierarchy are determinants of viral interference following influenza virus infection in a ferret model. The Journal of Infectious Diseases. 2015;212:1701–1710. doi: 10.1093/infdis/jiv260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv260</ArticleId><ArticleId IdType="pmc">PMC4633756</ArticleId><ArticleId IdType="pubmed">25943206</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EC, Arab A, Goldlust SM, Viboud C, Grenfell BT, Bansal S. Deploying digital health data to optimize influenza surveillance at national and local scales. PLOS Computational Biology. 2018;14:e1006020. doi: 10.1371/journal.pcbi.1006020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1006020</ArticleId><ArticleId IdType="pmc">PMC5858836</ArticleId><ArticleId IdType="pubmed">29513661</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Eguia R, Zost SJ, Choudhary S, Wilson PC, Bedford T, Stevens-Ayers T, Boeckh M, Hurt AC, Lakdawala SS, Hensley SE, Bloom JD. Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin. eLife. 2019;8:e49324. doi: 10.7554/eLife.49324.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.49324</ArticleId><ArticleId IdType="pmc">PMC6711711</ArticleId><ArticleId IdType="pubmed">31452511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DAT. Incubation periods of acute respiratory viral infections: a systematic review. The Lancet. Infectious Diseases. 2009;9:291–300. doi: 10.1016/S1473-3099(09)70069-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(09)70069-6</ArticleId><ArticleId IdType="pmc">PMC4327893</ArticleId><ArticleId IdType="pubmed">19393959</ArticleId></ArticleIdList></Reference><Reference><Citation>Lester RT, McGeer A, Tomlinson G, Detsky AS. Use of, effectiveness of, and attitudes regarding influenza vaccine among house staff. Infection Control &amp; Hospital Epidemiology. 2003;24:839–844. doi: 10.1086/502146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/502146</ArticleId><ArticleId IdType="pubmed">14649772</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, Hensley SE. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. The Journal of Experimental Medicine. 2013;210:1493–1500. doi: 10.1084/jem.20130212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20130212</ArticleId><ArticleId IdType="pmc">PMC3727314</ArticleId><ArticleId IdType="pubmed">23857983</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebhold A, Koenig WD, Bjørnstad ON. Spatial synchrony in population dynamics. Annual Review of Ecology, Evolution, and Systematics. 2004;35:467–490. doi: 10.1146/annurev.ecolsys.34.011802.132516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.ecolsys.34.011802.132516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu PJ, Singleton JA, Euler GL, Williams WW, Bridges CB. Seasonal influenza vaccination coverage among adult populations in the United States, 2005-2011. American Journal of Epidemiology. 2013;178:1478–1487. doi: 10.1093/aje/kwt158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwt158</ArticleId><ArticleId IdType="pmc">PMC5824626</ArticleId><ArticleId IdType="pubmed">24008912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu PJ, Hung MC, O’Halloran AC, Ding H, Srivastav A, Williams WW, Singleton JA. Seasonal influenza vaccination coverage trends among adult populations, U.S., 2010-2016. American Journal of Preventive Medicine. 2019;57:458–469. doi: 10.1016/j.amepre.2019.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2019.04.007</ArticleId><ArticleId IdType="pmc">PMC6755034</ArticleId><ArticleId IdType="pubmed">31473066</ArticleId></ArticleIdList></Reference><Reference><Citation>Luksza M, Lässig M. A predictive fitness model for influenza. Nature. 2014;507:57–61. doi: 10.1038/nature13087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13087</ArticleId><ArticleId IdType="pubmed">24572367</ArticleId></ArticleIdList></Reference><Reference><Citation>Margine I, Hai R, Albrecht RA, Obermoser G, Harrod AC, Banchereau J, Palucka K, García-Sastre A, Palese P, Treanor JJ, Krammer F. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. Journal of Virology. 2013;87:4728–4737. doi: 10.1128/JVI.03509-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03509-12</ArticleId><ArticleId IdType="pmc">PMC3624338</ArticleId><ArticleId IdType="pubmed">23408625</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, Belongia EA. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clinical Infectious Diseases. 2014;59:1375–1385. doi: 10.1093/cid/ciu680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu680</ArticleId><ArticleId IdType="pmc">PMC4207422</ArticleId><ArticleId IdType="pubmed">25270645</ArticleId></ArticleIdList></Reference><Reference><Citation>Memoli MJ, Shaw PA, Han A, Czajkowski L, Reed S, Athota R, Bristol T, Fargis S, Risos K, Powers JH, Davey RT, Taubenberger JK. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model. mBio. 2016;7:e00417. doi: 10.1128/mBio.00417-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00417-16</ArticleId><ArticleId IdType="pmc">PMC4959521</ArticleId><ArticleId IdType="pubmed">27094330</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P. Neutralizing antibodies against previously encountered influenza virus strains increase over time: A longitudinal analysis. Science Translational Medicine. 2013;5:198ra107. doi: 10.1126/scitranslmed.3006637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3006637</ArticleId><ArticleId IdType="pmc">PMC4091683</ArticleId><ArticleId IdType="pubmed">23946196</ArticleId></ArticleIdList></Reference><Reference><Citation>Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE. Antibody to influenza virus neuraminidase: An independent correlate of protection. The Journal of Infectious Diseases. 2015;212:1191–1199. doi: 10.1093/infdis/jiv195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv195</ArticleId><ArticleId IdType="pubmed">25858957</ArticleId></ArticleIdList></Reference><Reference><Citation>Muggeo VMR. Estimating regression models with unknown break-points. Statistics in Medicine. 2003;22:3055–3071. doi: 10.1002/sim.1545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1545</ArticleId><ArticleId IdType="pubmed">12973787</ArticleId></ArticleIdList></Reference><Reference><Citation>Muggeo V. Segmented: an R package to fit regression models with broken-line relationships. R News. 2008;8:20–25.</Citation></Reference><Reference><Citation>Murphy BR, Kasel JA, Chanock RM. Association of serum anti-neuraminidase antibody with resistance to influenza in man. The New England Journal of Medicine. 1972;286:1329–1332. doi: 10.1056/NEJM197206222862502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197206222862502</ArticleId><ArticleId IdType="pubmed">5027388</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers JL, Wetzel KS, Linderman SL, Li Y, Sullivan CB, Hensley SE. Compensatory hemagglutinin mutations alter antigenic properties of influenza viruses. Journal of Virology. 2013;87:11168–11172. doi: 10.1128/JVI.01414-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01414-13</ArticleId><ArticleId IdType="pmc">PMC3807274</ArticleId><ArticleId IdType="pubmed">23926344</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachbagauer R, Choi A, Izikson R, Cox MM, Palese P, Krammer F. Age dependence and isotype specificity of influenza virus hemagglutinin stalk-reactive antibodies in humans. mBio. 2016;7:e01996. doi: 10.1128/mBio.01996-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01996-15</ArticleId><ArticleId IdType="pmc">PMC4725014</ArticleId><ArticleId IdType="pubmed">26787832</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Interview Survey  TABLE: Self-reported influenza vaccination coverage trends 1989-2008 among adults by age group, risk group, race/ethnicity, health-care worker status, and pregnancy status. 2008.  [April 24, 2008]. https://www.cdc.gov/flu/pdf/fluvaxview/nhis89_08fluvaxtrendtab.pdf</Citation></Reference><Reference><Citation>Ndifon W, Dushoff J, Levin SA. On the use of hemagglutination-inhibition for influenza surveillance: surveillance data are predictive of influenza vaccine effectiveness. Vaccine. 2009;27:2447–2452. doi: 10.1016/j.vaccine.2009.02.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.02.047</ArticleId><ArticleId IdType="pubmed">19368786</ArticleId></ArticleIdList></Reference><Reference><Citation>Neher RA, Russell CA, Shraiman BI. Predicting evolution from the shape of genealogical trees. eLife. 2014;3:e03568. doi: 10.7554/eLife.03568.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.03568</ArticleId><ArticleId IdType="pmc">PMC4227306</ArticleId><ArticleId IdType="pubmed">25385532</ArticleId></ArticleIdList></Reference><Reference><Citation>Neher RA, Bedford T, Daniels RS, Russell CA, Shraiman BI. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses. PNAS. 2016;113:E1701–E1709. doi: 10.1073/pnas.1525578113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1525578113</ArticleId><ArticleId IdType="pmc">PMC4812706</ArticleId><ArticleId IdType="pubmed">26951657</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson MI, Holmes EC. The evolution of epidemic influenza. Nature Reviews. Genetics. 2007;8:196–205. doi: 10.1038/nrg2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2053</ArticleId><ArticleId IdType="pubmed">17262054</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Molecular Biology and Evolution. 2015;32:268–274. doi: 10.1093/molbev/msu300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msu300</ArticleId><ArticleId IdType="pmc">PMC4271533</ArticleId><ArticleId IdType="pubmed">25371430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, Jackson L, Meece JK, Nowalk MP, Song J, Zervos M, Cheng P-Y, Rinaldo CR, Clipper L, Shay DK, Piedra P, Monto AS. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clinical Infectious Diseases. 2014;58:319–327. doi: 10.1093/cid/cit736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cit736</ArticleId><ArticleId IdType="pmc">PMC4007111</ArticleId><ArticleId IdType="pubmed">24235265</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, Cohen C, Fry AM. Decreased influenza activity during the COVID-19 pandemic-United States. American Journal of Transplantation. 2020;20:3681–3685. doi: 10.1111/ajt.16381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16381</ArticleId><ArticleId IdType="pmc">PMC7753605</ArticleId><ArticleId IdType="pubmed">33264506</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, Kniss K, Burns E, Rowe T, Foust A, Jasso G, Merced-Morales A, Davis CT, Jang Y, Jones J, Daly P, Gubareva L, Barnes J, Kondor R, Sessions W, Smith C, Wentworth DE, Garg S, Havers FP, Fry AM, Hall AJ, Brammer L, Silk BJ. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020-2021. MMWR. Morbidity and Mortality Weekly Report. 2021;70:1013–1019. doi: 10.15585/mmwr.mm7029a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7029a1</ArticleId><ArticleId IdType="pmc">PMC8297694</ArticleId><ArticleId IdType="pubmed">34292924</ArticleId></ArticleIdList></Reference><Reference><Citation>Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, Reynolds A, Gunson R, Thompson C, Galiano M, Robertson C, Gallagher N, Sinnathamby M, Yonova I, Correa A, Moore C, Sartaj M, de Lusignan S, McMenamin J, Zambon M. End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17. Euro Surveillance. 2017;22:17-00306. doi: 10.2807/1560-7917.ES.2017.22.44.17-00306.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.44.17-00306</ArticleId><ArticleId IdType="pmc">PMC5710133</ArticleId><ArticleId IdType="pubmed">29113630</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei S, Kandula S, Yang W, Shaman J. Forecasting the spatial transmission of influenza in the United States. PNAS. 2018;115:2752–2757. doi: 10.1073/pnas.1708856115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708856115</ArticleId><ArticleId IdType="pmc">PMC5856508</ArticleId><ArticleId IdType="pubmed">29483256</ArticleId></ArticleIdList></Reference><Reference><Citation>Perofsky A. H3N2 antigenic epi. swh:1:rev:903dd3f1c669ef4c1687b15230d6c79ca9740a98Software Heritage. 2024 https://archive.softwareheritage.org/swh:1:dir:74c0de0f04e1a8fda9b100ff33216847f825f7e2;origin=https://github.com/aperofsky/H3N2_Antigenic_Epi;visit=swh:1:snp:b005c94d8e2ef5db3a29a79b512788634fbda7c0;anchor=swh:1:rev:903dd3f1c669ef4c1687b15230d6c79ca9740a98</Citation></Reference><Reference><Citation>Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nature Reviews. Microbiology. 2018;16:47–60. doi: 10.1038/nrmicro.2017.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.118</ArticleId><ArticleId IdType="pubmed">29109554</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. Canada Communicable Disease Report. 2005;31:181–191.</Citation><ArticleIdList><ArticleId IdType="pubmed">16669132</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y, Shaman J, Pei S. Quantifying the impact of COVID-19 nonpharmaceutical interventions on influenza transmission in the United States. The Journal of Infectious Diseases. 2021;224:1500–1508. doi: 10.1093/infdis/jiab485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab485</ArticleId><ArticleId IdType="pmc">PMC8522386</ArticleId><ArticleId IdType="pubmed">34551108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjeva S, Subramanian R, Fang VJ, Leung GM, Ip DKM, Perera RAPM, Peiris JSM, Cowling BJ, Cobey S. Age-specific differences in the dynamics of protective immunity to influenza. Nature Communications. 2019;10:1660. doi: 10.1038/s41467-019-09652-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09652-6</ArticleId><ArticleId IdType="pmc">PMC6458119</ArticleId><ArticleId IdType="pubmed">30971703</ArticleId></ArticleIdList></Reference><Reference><Citation>R Development Core Team  . Vienna, Austria: R Foundation for Statistical Computing; 2023. https://www.R-project.org/</Citation></Reference><Reference><Citation>Rolfes MA, Flannery B, Chung JR, O’Halloran A, Garg S, Belongia EA, Gaglani M, Zimmerman RK, Jackson ML, Monto AS, Alden NB, Anderson E, Bennett NM, Billing L, Eckel S, Kirley PD, Lynfield R, Monroe ML, Spencer M, Spina N, Talbot HK, Thomas A, Torres SM, Yousey-Hindes K, Singleton JA, Patel M, Reed C, Fry AM, McLean HQ, King JP, Nowalk MP, Balasubramani GK, Bear TM, Hickey R, Williams JV, Reis EC, Moehling KK, Eng H, Jackson LA, Smith M, Raiyani C, Clipper L, Murthy K, Chen W, Reis M, Petrie JG, Malosh RE, McSpadden EJ, Segaloff HE, Cheng CK, Truscon R, Johnson E, Lamerato LE, Rosenblum B, Ford S, Johnson M, Raviotta JM, Sax T, Steele J, Susick M, Chabra R, Garofolo E, Iozzi P, Kevish B, Middleton DB, Urbanski L, Ponder T, Crumbaker T, Iosefo I, Sleeth P, Gandy V, Bounds K, Kylberg M, Rao A, Fader R, Walker K, Volz M, Ray J, Price D, Thomas J, Wehbe-Janek H, Beeram M, Boyd J, Walkowiak J, Probe R, Couchman G, Motakef S, Arroliga A, Kaniclides A, Bouldin E, Baker C, Berke K, Smith M, Rajesh N, Alleman E, Bauer S, Groesbeck M, Brundidge K, Hafeez N, Jackson J, Anastasia I, Kadoo G, Petnic S, Ryan A, Maslar A, Meek J, Chen R, Stephens S, Thomas S, Segler S, Openo K, Fawcett E, Farley M, Martin A, Ryan P, Sunkel R, Lutich T, Perlmutter R, Grace B, Blood T, Zerrlaut C, McMahon M, Strain A, Christensen J, Angeles K, Butler L, Khanlian S, Mansmann R, McMullen C, Pradhan E, Manzi K, Felsen C, Gaitan M, Long K, Fisher N, Hawley E, O’Shaughnessy R, Scott M, Crawford C, Schaffner W, Markus T, Leib K, Dyer K, Santibanez T, Zhai Y, Lu P, Srivastav A, Hung M-C, US Influenza Vaccine Effectiveness (Flu VE) Network, the Influenza Hospitalization Surveillance Network, and the Assessment Branch, Immunization Services Division, Centers for Disease Control and Prevention Effects of influenza vaccination in the united states during the 2017–2018 influenza season. Clinical Infectious Diseases. 2019;69:1845–1853. doi: 10.1093/cid/ciz075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz075</ArticleId><ArticleId IdType="pmc">PMC7188082</ArticleId><ArticleId IdType="pubmed">30715278</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell KE, Fowlkes A, Stockwell MS, Vargas CY, Saiman L, Larson EL, LaRussa P, Di Lonardo S, Popowich M, St George K, Steffens A, Reed C. Comparison of outpatient medically attended and community-level influenza-like illness-New York City, 2013-2015. Influenza and Other Respiratory Viruses. 2018;12:336–343. doi: 10.1111/irv.12540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12540</ArticleId><ArticleId IdType="pmc">PMC5907822</ArticleId><ArticleId IdType="pubmed">29350791</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagulenko P, Puller V, Neher RA. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evolution. 2018;4:vex042. doi: 10.1093/ve/vex042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vex042</ArticleId><ArticleId IdType="pmc">PMC5758920</ArticleId><ArticleId IdType="pubmed">29340210</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandbulte MR, Westgeest KB, Gao J, Xu X, Klimov AI, Russell CA, Burke DF, Smith DJ, Fouchier RAM, Eichelberger MC. Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. PNAS. 2011;108:20748–20753. doi: 10.1073/pnas.1113801108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1113801108</ArticleId><ArticleId IdType="pmc">PMC3251064</ArticleId><ArticleId IdType="pubmed">22143798</ArticleId></ArticleIdList></Reference><Reference><Citation>Sax C, Steiner P. Temporal disaggregation of time series. The R Journal. 2013;5:80. doi: 10.32614/RJ-2013-028.</Citation><ArticleIdList><ArticleId IdType="doi">10.32614/RJ-2013-028</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman JL, Khakpour M, Kilbourne ED. Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. Journal of Virology. 1968;2:778–786. doi: 10.1128/JVI.2.8.778-786.1968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.2.8.778-786.1968</ArticleId><ArticleId IdType="pmc">PMC375691</ArticleId><ArticleId IdType="pubmed">5701819</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman JL, Kilbourne ED. Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus. PNAS. 1969;63:326–333. doi: 10.1073/pnas.63.2.326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.63.2.326</ArticleId><ArticleId IdType="pmc">PMC223568</ArticleId><ArticleId IdType="pubmed">5257124</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott JA, Gandy A, Mishra S, Bhatt S, Flaxman S, Unwin HJT, Ish-Horowicz J. Epidemia: an R package for semi-mechanistic bayesian modelling of infectious diseases using point processes. arXiv. 2021 doi: 10.48550/arXiv.2110.12461.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2110.12461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaman J, Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. PNAS. 2009;106:3243–3248. doi: 10.1073/pnas.0806852106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0806852106</ArticleId><ArticleId IdType="pmc">PMC2651255</ArticleId><ArticleId IdType="pubmed">19204283</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaman J, Pitzer VE, Viboud C, Grenfell BT, Lipsitch M. Absolute humidity and the seasonal onset of influenza in the continental United States. PLOS Biology. 2010;8:e1000316. doi: 10.1371/journal.pbio.1000316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000316</ArticleId><ArticleId IdType="pmc">PMC2826374</ArticleId><ArticleId IdType="pubmed">20186267</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon CE. A mathematical theory of communication. Bell System Technical Journal. 1948;27:379–423. doi: 10.1002/j.1538-7305.1948.tb01338.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1538-7305.1948.tb01338.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih AC-C, Hsiao T-C, Ho M-S, Li W-H. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. PNAS. 2007;104:6283–6288. doi: 10.1073/pnas.0701396104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0701396104</ArticleId><ArticleId IdType="pmc">PMC1851070</ArticleId><ArticleId IdType="pubmed">17395716</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveillance. 2017;22:30494. doi: 10.2807/1560-7917.ES.2017.22.13.30494.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.13.30494</ArticleId><ArticleId IdType="pmc">PMC5388101</ArticleId><ArticleId IdType="pubmed">28382917</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine. 1999;17:S3–S10. doi: 10.1016/S0264-410X(99)00099-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(99)00099-7</ArticleId><ArticleId IdType="pubmed">10471173</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen L, Viboud C. The art of modeling the mortality impact of winter-seasonal pathogens. Journal of Infectious Diseases. 2012;206:625–627. doi: 10.1093/infdis/jis419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis419</ArticleId><ArticleId IdType="pubmed">22723644</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson CR, Lone NI, Kavanagh K, Ritchie LD, Robertson C, Sheikh A, McMenamin J. Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009. Eurosurveillance. 2015;20:21043. doi: 10.2807/1560-7917.ES2015.20.8.21043.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES2015.20.8.21043</ArticleId><ArticleId IdType="pubmed">25742433</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G. Estimating vaccine effectiveness against laboratory-confirmed influenza using A sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine. 2007;25:2842–2851. doi: 10.1016/j.vaccine.2006.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2006.10.002</ArticleId><ArticleId IdType="pubmed">17081662</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. The Journal of Infectious Diseases. 2009;199:168–179. doi: 10.1086/595862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/595862</ArticleId><ArticleId IdType="pubmed">19086914</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, Ouhoummane N, Willison DJ, Rouleau I, Petric M, Fonseca K, Drews SJ, Rebbapragada A, Charest H, Hamelin M-E, Boivin G, Gardy JL, Li Y, Kwindt TL, Patrick DM, Brunham RC, Canadian SAVOIR Team Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLOS Medicine. 2010;7:e1000258. doi: 10.1371/journal.pmed.1000258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000258</ArticleId><ArticleId IdType="pmc">PMC2850386</ArticleId><ArticleId IdType="pubmed">20386731</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, Gubbay J, Fonseca K, Charest H, Crowcroft NS, Fradet MD, Bastien N, Li Y, Krajden M, Sabaiduc S, Petric M. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clinical Infectious Diseases. 2012;55:332–342. doi: 10.1093/cid/cis431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis431</ArticleId><ArticleId IdType="pubmed">22539661</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter A-L, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLOS ONE. 2014a;9:e92153. doi: 10.1371/journal.pone.0092153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092153</ArticleId><ArticleId IdType="pmc">PMC3965421</ArticleId><ArticleId IdType="pubmed">24667168</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. The Journal of Infectious Diseases. 2014b;210:126–137. doi: 10.1093/infdis/jiu048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu048</ArticleId><ArticleId IdType="pubmed">24446529</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Krajden M, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Kwindt TL, Bastien N, Li Y. A perfect storm: Impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014-2015 season. Clinical Infectious Diseases. 2016;63:21–32. doi: 10.1093/cid/ciw176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw176</ArticleId><ArticleId IdType="pmc">PMC4901864</ArticleId><ArticleId IdType="pubmed">27025838</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y, Smith DJ. Serial vaccination and the antigenic distance hypothesis: Effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-2011 to 2014-2015. The Journal of Infectious Diseases. 2017a;215:1059–1099. doi: 10.1093/infdis/jix074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix074</ArticleId><ArticleId IdType="pmc">PMC5853783</ArticleId><ArticleId IdType="pubmed">28180277</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter A-L, De Serres G, Drews SJ, Jassem A, Gubbay JB, Charest H, Balshaw R, Bastien N, Li Y, Krajden M. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. Euro Surveillance. 2017b;22:30460. doi: 10.2807/1560-7917.ES.2017.22.6.30460.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.6.30460</ArticleId><ArticleId IdType="pmc">PMC5316907</ArticleId><ArticleId IdType="pubmed">28205503</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Leir S, Sabaiduc S, Chambers C, Zou M, Rose C, Olsha R, Dickinson JA, Winter A-L, Jassem A, Gubbay JB, Drews SJ, Charest H, Chan T, Hickman R, Bastien N, Li Y, Krajden M, De Serres G. Influenza vaccine effectiveness by A(H3N2) phylogenetic subcluster and prior vaccination history: 2016-2017 and 2017-2018 epidemics in Canada. The Journal of Infectious Diseases. 2022;225:1387–1398. doi: 10.1093/infdis/jiaa138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa138</ArticleId><ArticleId IdType="pmc">PMC9016427</ArticleId><ArticleId IdType="pubmed">32215564</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus A, Fouchier RAM. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305:371–376. doi: 10.1126/science.1097211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1097211</ArticleId><ArticleId IdType="pubmed">15218094</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GJD, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JSM, Guan Y, Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009;459:1122–1125. doi: 10.1038/nature08182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08182</ArticleId><ArticleId IdType="pubmed">19516283</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonoguchi T, Naito H, Hara M, Takeuchi Y, Fukumi H. Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. The Journal of Infectious Diseases. 1985;151:81–88. doi: 10.1093/infdis/151.1.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/151.1.81</ArticleId><ArticleId IdType="pubmed">3965596</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, Bean T, Barclay W, Deeks JJ, Lalvani A. Cellular immune correlates of protection against symptomatic pandemic influenza. Nature Medicine. 2013;19:1305–1312. doi: 10.1038/nm.3350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3350</ArticleId><ArticleId IdType="pubmed">24056771</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar S. Heterosubtypic T-cell immunity to influenza in humans: challenges for universal T-cell influenza vaccines. Frontiers in Immunology. 2016;7:195. doi: 10.3389/fimmu.2016.00195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00195</ArticleId><ArticleId IdType="pmc">PMC4871858</ArticleId><ArticleId IdType="pubmed">27242800</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhoff MC, Fries LF, Karron RA, Clements ML, Murphy BR. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children. Journal of Clinical Microbiology. 1993;31:836–838. doi: 10.1128/jcm.31.4.836-838.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.31.4.836-838.1993</ArticleId><ArticleId IdType="pmc">PMC263573</ArticleId><ArticleId IdType="pubmed">8463393</ArticleId></ArticleIdList></Reference><Reference><Citation>Strobl C, Boulesteix AL, Zeileis A, Hothorn T. Bias in random forest variable importance measures: illustrations, sources and a solution. BMC Bioinformatics. 2007;8:25. doi: 10.1186/1471-2105-8-25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-8-25</ArticleId><ArticleId IdType="pmc">PMC1796903</ArticleId><ArticleId IdType="pubmed">17254353</ArticleId></ArticleIdList></Reference><Reference><Citation>Strobl C, Boulesteix AL, Kneib T, Augustin T, Zeileis A. Conditional variable importance for random forests. BMC Bioinformatics. 2008;9:307. doi: 10.1186/1471-2105-9-307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-307</ArticleId><ArticleId IdType="pmc">PMC2491635</ArticleId><ArticleId IdType="pubmed">18620558</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y. Positive selection operates continuously on hemagglutinin during evolution of H3N2 human influenza A virus. Gene. 2008;427:111–116. doi: 10.1016/j.gene.2008.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2008.09.012</ArticleId><ArticleId IdType="pubmed">18848975</ArticleId></ArticleIdList></Reference><Reference><Citation>Tempia S, Walaza S, Bhiman JN, McMorrow ML, Moyes J, Mkhencele T, Meiring S, Quan V, Bishop K, McAnerney JM, von Gottberg A, Wolter N, Du Plessis M, Treurnicht FK, Hellferscee O, Dawood H, Naby F, Variava E, Siwele C, Baute N, Nel J, Reubenson G, Zar HJ, Cohen C. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveillance. 2021;26:2001600. doi: 10.2807/1560-7917.ES.2021.26.29.2001600.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.29.2001600</ArticleId><ArticleId IdType="pmc">PMC8299743</ArticleId><ArticleId IdType="pubmed">34296675</ArticleId></ArticleIdList></Reference><Reference><Citation>Terajima M, Babon JAB, Co MDT, Ennis FA. Cross-reactive human B cell and T cell epitopes between influenza A and B viruses. Virology Journal. 2013;10:244. doi: 10.1186/1743-422X-10-244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-244</ArticleId><ArticleId IdType="pmc">PMC3726517</ArticleId><ArticleId IdType="pubmed">23886073</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrence C, Compo GP. A practical guide to wavelet analysis. Bulletin of the American Meteorological Society. 1998;79:61–78. doi: 10.1175/1520-0477(1998)079&lt;0061:APGTWA&gt;2.0.CO;2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1175/1520-0477(1998)079&lt;0061:APGTWA&gt;2.0.CO;2</ArticleId></ArticleIdList></Reference><Reference><Citation>Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, Shay DK, Network USFV. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clinical Infectious Diseases. 2012;55:951–959. doi: 10.1093/cid/cis574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis574</ArticleId><ArticleId IdType="pmc">PMC3657521</ArticleId><ArticleId IdType="pubmed">22843783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulmer JB, Fu TM, Deck RR, Friedman A, Guan L, DeWitt C, Liu X, Wang S, Liu MA, Donnelly JJ, Caulfield MJ. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. Journal of Virology. 1998;72:5648–5653. doi: 10.1128/JVI.72.7.5648-5653.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.7.5648-5653.1998</ArticleId><ArticleId IdType="pmc">PMC110229</ArticleId><ArticleId IdType="pubmed">9621023</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenciano M, Kissling E, Larrauri A, Nunes B, Pitigoi D, O’Donnell J, Reuss A, Horváth JK, Paradowska-Stankiewicz I, Rizzo C, Falchi A, Daviaud I, Brytting M, Meijer A, Kaic B, Gherasim A, Machado A, Ivanciuc A, Domegan L, Schweiger B, Ferenczi A, Korczyńska M, Bella A, Vilcu A-M, Mosnier A, Zakikhany K, de Lange M, Kurečić Filipovićović S, Johansen K, Moren A, I-MOVE primary care multicentre case-control team Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017. Influenza and Other Respiratory Viruses. 2018;12:567–581. doi: 10.1111/irv.12562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12562</ArticleId><ArticleId IdType="pmc">PMC6086844</ArticleId><ArticleId IdType="pubmed">29659149</ArticleId></ArticleIdList></Reference><Reference><Citation>van Doorn E, Darvishian M, Dijkstra F, Donker GA, Overduin P, Meijer A, Hak E. Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: the test-negative design case-control study with different control groups. Vaccine. 2017;35:2831–2839. doi: 10.1016/j.vaccine.2017.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.04.012</ArticleId><ArticleId IdType="pmc">PMC7126814</ArticleId><ArticleId IdType="pubmed">28412077</ArticleId></ArticleIdList></Reference><Reference><Citation>Viboud C, Boëlle PY, Pakdaman K, Carrat F, Valleron AJ, Flahault A. Influenza epidemics in the United States, France, and Australia, 1972-1997. Emerging Infectious Diseases. 2004;10:32–39. doi: 10.3201/eid1001.020705.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1001.020705</ArticleId><ArticleId IdType="pmc">PMC3322745</ArticleId><ArticleId IdType="pubmed">15078594</ArticleId></ArticleIdList></Reference><Reference><Citation>Viboud C, Bjørnstad ON, Smith DL, Simonsen L, Miller MA, Grenfell BT. Synchrony, waves, and spatial hierarchies in the spread of influenza. Science. 2006;312:447–451. doi: 10.1126/science.1125237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1125237</ArticleId><ArticleId IdType="pubmed">16574822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward B, Clarke T, Freeman G, Schiller J.  Early Release of Selected Estimates Based on Data From the 2014 National Health Interview Survey. National Center for Health Statistics; 2015. https://www.cdc.gov/nchs/nhis/releases/released201506.htm</Citation></Reference><Reference><Citation>Ward B, Clarke T, Nugent C, Schiller J.  Early Release of Selected Estimates Based on Data From the 2015 National Health Interview Survey. National Center for Health Statistics; 2016. https://www.cdc.gov/nchs/nhis/releases/released201605.htm</Citation></Reference><Reference><Citation>Webster RG, Laver WG. Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology. 1980;104:139–148. doi: 10.1016/0042-6822(80)90372-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(80)90372-4</ArticleId><ArticleId IdType="pubmed">6156537</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster RG, Laver WG, Air GM, Schild GC. Molecular mechanisms of variation in influenza viruses. Nature. 1982;296:115–121. doi: 10.1038/296115a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/296115a0</ArticleId><ArticleId IdType="pubmed">6174870</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiological Reviews. 1992;56:152–179. doi: 10.1128/mr.56.1.152-179.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mr.56.1.152-179.1992</ArticleId><ArticleId IdType="pmc">PMC372859</ArticleId><ArticleId IdType="pubmed">1579108</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger DM, Krause TG, Mølbak K, Cliff A, Briem H, Viboud C, Gottfredsson M. Influenza epidemics in Iceland over 9 decades: changes in timing and synchrony with the United States and Europe. American Journal of Epidemiology. 2012;176:649–655. doi: 10.1093/aje/kws140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kws140</ArticleId><ArticleId IdType="pmc">PMC3530371</ArticleId><ArticleId IdType="pubmed">22962250</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley DC, Wilson IA, Skehel JJ. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature. 1981;289:373–378. doi: 10.1038/289373a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/289373a0</ArticleId><ArticleId IdType="pubmed">6162101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annual Review of Immunology. 1990;8:737–771. doi: 10.1146/annurev.iy.08.040190.003513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.iy.08.040190.003513</ArticleId><ArticleId IdType="pubmed">2188678</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohlbold TJ, Nachbagauer R, Xu H, Tan GS, Hirsh A, Brokstad KA, Cox RJ, Palese P, Krammer F. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. mBio. 2015;6:e02556. doi: 10.1128/mBio.02556-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02556-14</ArticleId><ArticleId IdType="pmc">PMC4453582</ArticleId><ArticleId IdType="pubmed">25759506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf YI, Viboud C, Holmes EC, Koonin EV, Lipman DJ. Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biology Direct. 2006;1:34. doi: 10.1186/1745-6150-1-34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6150-1-34</ArticleId><ArticleId IdType="pmc">PMC1647279</ArticleId><ArticleId IdType="pubmed">17067369</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf YI, Nikolskaya A, Cherry JL, Viboud C, Koonin E, Lipman DJ. Projection of seasonal influenza severity from sequence and serological data. PLOS Currents. 2010;2:RRN1200. doi: 10.1371/currents.RRN1200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/currents.RRN1200</ArticleId><ArticleId IdType="pmc">PMC2998708</ArticleId><ArticleId IdType="pubmed">21152078</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Global Influenza Programme: FluNet. 2023.  [September 5, 2024]. https://www.who.int/tools/flunet</Citation></Reference><Reference><Citation>Wraith S, Balmaseda A, Carrillo FAB, Kuan G, Huddleston J, Kubale J, Lopez R, Ojeda S, Schiller A, Lopez B, Sanchez N, Webby R, Nelson MI, Harris E, Gordon A. Homotypic protection against influenza in a pediatric cohort in Managua, Nicaragua. Nature Communications. 2022;13:1190. doi: 10.1038/s41467-022-28858-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28858-9</ArticleId><ArticleId IdType="pmc">PMC8897407</ArticleId><ArticleId IdType="pubmed">35246548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu A, Peng Y, Du X, Shu Y, Jiang T. Correlation of influenza virus excess mortality with antigenic variation: application to rapid estimation of influenza mortality burden. PLOS Computational Biology. 2010;6:e1000882. doi: 10.1371/journal.pcbi.1000882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1000882</ArticleId><ArticleId IdType="pmc">PMC2920844</ArticleId><ArticleId IdType="pubmed">20711361</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie H, Wan XF, Ye Z, Plant EP, Zhao Y, Xu Y, Li X, Finch C, Zhao N, Kawano T, Zoueva O, Chiang MJ, Jing X, Lin Z, Zhang A, Zhu Y. H3N2 Mismatch of 2014-15 northern hemisphere influenza vaccines and head-to-head comparison between human and ferret antisera derived antigenic maps. Scientific Reports. 2015;5:15279. doi: 10.1038/srep15279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15279</ArticleId><ArticleId IdType="pmc">PMC4607887</ArticleId><ArticleId IdType="pubmed">26472175</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, Neher RA, Shraiman BI. Phylodynamic theory of persistence, extinction and speciation of rapidly adapting pathogens. eLife. 2019;8:e44205. doi: 10.7554/eLife.44205.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.44205</ArticleId><ArticleId IdType="pmc">PMC6809594</ArticleId><ArticleId IdType="pubmed">31532393</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Lau EHY, Cowling BJ. Dynamic interactions of influenza viruses in Hong Kong during 1998-2018. PLOS Computational Biology. 2020;16:e1007989. doi: 10.1371/journal.pcbi.1007989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1007989</ArticleId><ArticleId IdType="pmc">PMC7316359</ArticleId><ArticleId IdType="pubmed">32542015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang A, Stacey HD, Mullarkey CE, Miller MS. Original antigenic sin: how first exposure shapes lifelong anti-influenza virus immune responses. Journal of Immunology. 2019;202:335–340. doi: 10.4049/jimmunol.1801149.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1801149</ArticleId><ArticleId IdType="pubmed">30617114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Wulder MA, Hu T, Bright R, Wu Q, Qin H, Li Y, Toman E, Mallick B, Zhang X, Brown M. Detecting change-point, trend, and seasonality in satellite time series data to track abrupt changes and nonlinear dynamics: A Bayesian ensemble algorithm. Remote Sensing of Environment. 2019;232:111181. doi: 10.1016/j.rse.2019.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rse.2019.04.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B, Investigators USFV, Investigators USFV. 2014-2015 influenza vaccine effectiveness in the United States by vaccine type. Clinical Infectious Diseases. 2016;63:1564–1573. doi: 10.1093/cid/ciw635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw635</ArticleId><ArticleId IdType="pmc">PMC5146719</ArticleId><ArticleId IdType="pubmed">27702768</ArticleId></ArticleIdList></Reference><Reference><Citation>Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. PNAS. 2017;114:12578–12583. doi: 10.1073/pnas.1712377114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1712377114</ArticleId><ArticleId IdType="pmc">PMC5703309</ArticleId><ArticleId IdType="pubmed">29109276</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>